Colfax Corp. (CFX) Tops Q1 EPS by 4c, Revenues Beat; Raises FY21 EPS Guidance, Provides 2Q EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Colfax Announces First Quarter 2021 Results
April 29, 2021 6:00 AM EDTReported $0.19 EPS from continuing operations and achieved $0.44 of adjusted EPSGrew sales 8% including organic sales-per-day growth of 9%Recently announced expanded fast-growing foot & ankle business with April acquisition of MedShapeRaising low-end of adjusted 2021 EPS guidance range to $2.05-$2.15
ANNAPOLIS JUNCTION, MD, April 29, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its... More



